8-KEarnings & ResultsExhibits & Filings

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Feb 2, 2012)

Filed February 2, 2012For Securities:GILD

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K on February 2, 2012, to report its financial results for the fourth quarter and full year ended December 31, 2011. The filing primarily serves to attach the press release detailing these results, which includes both GAAP and non-GAAP financial information. While the 8-K itself does not contain the detailed financial figures, it directs investors to Exhibit 99.1, the press release, for comprehensive information on revenue, earnings, and other key performance indicators. Management's use of non-GAAP measures is highlighted as a tool for internal financial planning and operational assessment, with a disclaimer that these measures should supplement, not replace, GAAP reporting.

Key Highlights

  • 1Gilead Sciences announced its financial results for Q4 and full year 2011 via an 8-K filing on February 2, 2012.
  • 2The primary purpose of the 8-K is to furnish the press release containing the detailed financial results as Exhibit 99.1.
  • 3The press release includes financial information presented on both a GAAP and non-GAAP basis.
  • 4Management believes non-GAAP financial information is useful for investors and for internal operational and financial planning.
  • 5A reconciliation between GAAP and non-GAAP financial information is provided within the press release (Exhibit 99.1).
  • 6The information furnished in the 8-K and its exhibits is not deemed 'filed' for certain sections of the Securities Exchange Act of 1934, limiting liability under Section 18.
  • 7Robin L. Washington, Senior Vice President and Chief Financial Officer, signed the report, indicating CFO-level review of the disclosed financial information.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce and provide access to Gilead Sciences' financial results for the fourth quarter and the full fiscal year ended December 31, 2011. It does so by attaching the official press release detailing these results as an exhibit.

The detailed financial results are provided in the press release issued by Gilead Sciences on February 2, 2012, which is included as Exhibit 99.1 to this 8-K filing.

Yes, Gilead Sciences reports its financial results for the period using both Generally Accepted Accounting Principles (GAAP) and non-GAAP measures. Management considers non-GAAP measures useful for understanding operational performance, but they should be analyzed in conjunction with, and not as a substitute for, GAAP reporting.

No, the information contained in this Form 8-K and its attached exhibits is specifically stated as not being 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. This limits the company's liability concerning this specific disclosure.